20 likes | 110 Views
Genomics Research and Intellectual Property April 28, 2011. Marshall Moffat President mc squared Professional Services. Commentary From The Policymakers’ Perspective. About me Bouquet Policymaking is a multi-splendored thing Federal policymaker perspectives
E N D
Genomics Research and Intellectual PropertyApril 28, 2011 Marshall Moffat President mc squared Professional Services
Commentary From The Policymakers’ Perspective • About me • Bouquet • Policymaking is a multi-splendored thing • Federal policymaker perspectives • The big eight policy objectives (economy, international, health, environment, social, justice and security, governance, Aboriginal peoples) • Innovation economic policy framework (Marketplace and Trade, Knowledge and R&D investment, Innovation and Entrepreneurs, People) • R&D policy and investment (SRED, Granting Agencies and Foundations, Govt Science, IRAP etc.) • Commercialization problem and expectation (pay-off) • Key commercialization weaknesses • Business/academe collaboration • Venture capital • First market (e.g. CICP) • Genomics / IP Management Bottom line • No one size fits all • Gestation periods affect what works best (amount of knowledge networking and/or business case development required) • Options 1, 2 and 3 • ICT vs Genomic research; different types of genomics research • Commercialization of university research discoveries • Two solitudes (business and academe, receptors and publish or perish) • The NCE Programs and ex-ante collaboration • Venture Capital and first market • Future Work: Case studies to develop a model for determining optimum IP approaches • ICT vs Genomics • Characteristics for different types of genomics research